UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC, PAR PHARMACEUTICAL, INC. and
`WOCKHARDT BIO AG,
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-005541
`Patent 7,668,730
`________________
`
`DECLARATION OF DAVID A. HOLDFORD, PH.D., FAPhA
`
`
`
`
`
`
`
`
`1 Case IPR2015-01818 has been joined with this proceeding.
`
`
`
`JAZZ EXHIBIT 2056
`Amneal Pharms. et al. (Petitioners) v. Jazz Pharms., Inc. (Patent Owner)
`Case IPR2015-00554
`
`Page 1 of 32
`
`

`
`
`
`I, David A. Holdford, Ph.D., FAPhA, hereby declare and state as follows:
`
`1.
`
`I submit this declaration on behalf of Jazz Pharmaceuticals, Inc.
`
`(“Jazz”), Patent Owner of U.S. Patent No. 7,668,730 (the “’730 patent”) in
`
`connection with this inter partes review, Case IPR2015-00554.
`
`2.
`
`I have been engaged in the profession of pharmacy for 34 years as a
`
`pharmacist, educator, researcher, and consultant.
`
`3.
`
`I received a Bachelor of Science degree in pharmacy from the
`
`University of Illinois at Chicago in 1980, a Master of Science degree in pharmacy
`
`from Ohio State University in 1981, and a Ph.D. in Pharmacy Administration from
`
`the University of South Carolina in 1995.
`
`4.
`
`I am currently a Professor in the Department of Pharmacotherapy and
`
`Outcomes Science at Virginia Commonwealth University School of Pharmacy. I
`
`teach and conduct research in the areas of health outcomes, practice management,
`
`and pharmacoeconomics. Prior to entering academia, I practiced as a hospital
`
`pharmacist in Chicago and South Carolina.
`
`5.
`
`As part of my teaching duties, I have designed, managed, and
`
`instructed in several courses including PHAR 660 Pharmacy Practice Management
`
`I, Community Practice; PHAR 661 Pharmacy Practice Management II -
`
`Institutional Practice, and PHAR 547 Managing Professional Patient Centered
`
`Practice. These courses are required for all of our pharmacy students. In addition, I
`
`
`
`
`
`Page 2 of 32
`
`

`
`
`
`
`
`
`
`
`
`authored the textbooks for PHAR 600 and 661 and am completing the textbook
`
`manuscript for PHAR 547.
`
`6.
`
`At the American Association of Colleges of Pharmacy (AACP), I am
`
`currently the Chair of the Social and Administrative Sciences Section. In my roles
`
`at AACP, I have studied the curricula at schools of pharmacy across the US and
`
`am familiar with what topics are commonly taught. I have received awards from
`
`the FDA and the Academy for Healthcare Improvement for my work on curricula
`
`in medication safety and quality.
`
`7.
`
`In my various academic roles, I have become familiar with
`
`commonly-used sources of information for pharmacists to consult as aids in
`
`distributing, managing, and providing education about pharmaceuticals. These are
`
`the information sources that will be relevant and useful to the students’ pharmacy
`
`practice once they have graduated and are practicing, registered pharmacists. I do
`
`not teach about the Federal Register, nor do I consider it one of the commonly-
`
`used sources of information at US pharmacy schools.
`
`
`
`
`
`- 2 -
`
`Page 3 of 32
`
`

`
`
`
`
`
`
`
`
`
`Executed this 6th day of November 2015. I declare under penalty of
`
`perjury that the foregoing is true and correct.
`
`
`
`_______________________________
`David A. Holdford, Ph.D., FAPhA
`
`
`
`
`- 3 -
`
`Page 4 of 32
`
`

`
`Exhibit 1
`
`Exhibit 1
`
`
`
`
`
`
`
`
`
`
`Page 5 of 32
`
`

`
`David A. Holdford, RPh, MS, PhD, FAPhA
`Curriculum Vitae
`
`
`
`
`
`
`
`
`
`
`
`
`BUSINESS ADDRESS:
`
`Virginia Commonwealth University (MCV Campus)
`College of Pharmacy
`
`
`
`
`P.O. Box 980533
`
`
`
`
`Richmond, Virginia 23298-0533
`
`
`(804) 828-6103
`
`E-MAIL: DAVID.HOLDFORD@VCU.EDU
`
`
`
`HOME ADDRESS:
`
`4909 Evelyn Byrd Road
`Richmond, Virginia
`23225
`(804) 231-0678
`
`
`
`
`
`University of South Carolina (1995)
`
`
`
`Ohio State University (1981)
`
`
`
`University of Illinois, Chicago (1980)
`
`
`
`
`EDUCATION
`
`Ph.D. in Pharmacy
`Administration
`
`
`
`M.S. in Pharmacy
`Administration
`
`B.S. in Pharmacy
`
`
`
`
`PROFESSIONAL EXPERIENCE
`
`ACADEMIA
`
`2011 to present
`
`Professor, Pharmacy Administration. School of Pharmacy, Virginia
`Commonwealth University (MCV Campus).
`
`Associate Professor, Pharmacy Administration. School of Pharmacy, Virginia
`Commonwealth University (MCV Campus).
`
`
`
`Vice-Chair, Graduate Program, Dept of Pharmacy. School of Pharmacy,
`Virginia Commonwealth University (MCV Campus).
`
`
`
`Assistant Professor, Pharmacy Administration. School of Pharmacy, Virginia
`Commonwealth University (MCV Campus).
`
`
`
`Poison Center Pharmacist. Palmetto Poison Center. School of Pharmacy,
`University of South Carolina.
`
`
`
`Teaching Assistant. School of Pharmacy. University of South Carolina.
`
`
`
`Pharmacist/Inpatient Supervisor. Lexington Medical Center. West
`Columbia, South Carolina.
`
`Staff Pharmacist. Grant Hospital. Chicago, Illinois.
`
`
`
`Page 1
`
`
`
`2002 to 2011
`
`
`
`
`
`2004 to 2006,
`2009 to 2014
`
`
`1995 to 2002
`
`
`
`1993 to 1995
`
`
`
`1992 to 1995
`
`PRACTICE
`
`1985 to 1992
`
`
`
`1981 to 1985
`
`
`
`David A. Holdford
`
`
`Page 6 of 32
`
`

`
`
`PROFESSIONAL LICENSURE
`
`Registered Pharmacist: Ohio (1980), Illinois (1981), and South Carolina (1985).
`
`
`
`RECENT HONORS AND AWARDS
`
`
`-
`
`2015 Duncan Neuhauser Award for Curricular Innovation from the Academy for Healthcare
`
`Improvement for work by a team of educators in developing the Educating Pharmacists in Quality
`
`(EPIQ) Program. Other team members were Terri Warholak (The University of Arizona), Vibhuti
`
`Arya (St. John’s University & NYC Health Department), Ana Hincapie (University of Cincinnati),
`
`and Donna West (University of Mississippi)
`
`-
`
`2015 AACP Rufus A. Lyman Award to the author of the best paper published in the
`
`American Journal of Pharmaceutical Education for "Holdford DA. Is a Pharmacy Student the
`
`Customer or the Product?"
`
`-
`
`2015 APhA-APRS Wiederholt Prize for best published paper in the Journal of the American
`
`Pharmacists Association in economic, social, or administrative sciences for "Adherence and
`
`persistence associated with an appointment-based medication synchronization program."
`
`-
`
`2014 National Community Pharmacists Association (NCPA) Outstanding Adherence Educator
`
`Award
`
`- American Association of Colleges of Pharmacy (AACP) 2015 Chair Social and Administrative
`
`Sciences Section
`
`- AACP’s 2012-2013 Academic Leadership Fellows Program
`
`-
`
`-
`
`2012-2013 VCU Online Course Development Initiative
`
`2012 Exceptional Reviewer Journal of Rural Health
`
`- Top Reviewer for the Journal Research in Social and Administrative Pharmacy for 2011.
`
`-
`
`FDA Leveraging/Collaboration Award for the "Science of Safety" group at the 15th Annual
`
`Office of the Commissioner, Honor Awards Ceremony held June 4, 2010. The FDA
`
`Leveraging/Collaboration Award was presented for creativity in establishing a unique
`
`collaboration to aid the agency in meeting its mandates to advance the science of medical
`
`product safety.
`
`- Named APhA-APRS Fellow at the American Pharmacists Association’s 2009 annual meeting,
`
`April 3-6, San Antonio, Texas.
`
`- AACP Walmart Scholars Program mentor – Toni Coe (2008), Tim Inocencio (2012)
`
`Page 2
`
`
`
`David A. Holdford
`
`
`Page 7 of 32
`
`

`
`
`BOOKS AND MANUALS AUTHORED/EDITED
`
`Holdford, David A. Marketing for Pharmacists: Providing and Promoting Professional Services, 3nd Edition.
`Pharmaco Enterprise Publishing; pp.330; 2015.
`
`Holdford DA, Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed.
`Bethesda, Maryland: American Society of Health-Systems Pharmacists; pp. 404; 2010.
`
`Holdford, David A. (Editor). Pharmacy and the Pharmaceutical Industry: Healing the Rift.
`The Haworth Press, Birmingham, N.Y. 2008. pp. 1-108; 2008.
`
`Cynthia J. Boyle (Editor), Robert S. Beardsley (Editor), David A. Holdford (Editor). Leadership and
`Advocacy for Pharmacy. American Pharmacists Association Publications, Washington, DC. pp. 1-196;
`2007.
`
`Holdford, David A. (Author/Editor) Marketing for Pharmacists: Providing and Promoting Professional
`Services, 2nd Edition. American Pharmacists Association Publications, Washington, DC. pp. 1-333; 2007.
`
`Holdford, David A. (Author) Instructors Manual: Marketing for Pharmacists 2nd Edition. American
`Pharmacists Association Publications, Washington, DC. pp. 1-49; 2007.
`
`Holdford DA. Marketing for Pharmacists. 1st Edition. American Pharmaceutical Association Publications,
`Washington, DC. pp. 1-298; 2003.
`
`
`
`PEER-REVIEWED PUBLICATIONS
`*Students or residents under my direction are indicated by an asterisk
`
`Holdford DA, Saxena K. Impact of an appointment-based medication synchronization program on
`adherence and persistence with existing users of chronic medications. Journal of Managed Care and
`Specialty Pharmacy. Aug;21(8):662-9, 2015.
`
`Carroll NV, Rupp MT, Holdford DA. Analysis of Costs to Dispense Prescriptions in Independently-Owned
`Closed –Door Long-term Care Pharmacies. Journal of Managed Care & Specialty Pharmacy, 20(3): March
`2014.
`
`Holdford DA. Is a Pharmacy Student the Customer or the Product? American Journal of Pharmaceutical
`Education 2014; 78 (1) Article 3.
`
`Holdford DA. Inocencio TJ. Adherence and persistence associated a medication synchronization program.
`J Am Pharm Assoc. 2013; 53:576–583.
`
`Gupta R, Holdford DA, Bilaver L, Dyer A, Holl J, Meltzer D. The Economic Impact of Childhood Food
`Allergy in the United States. JAMA Pediatrics. 2013; 167(11):1026-31.
`
`*Inocencio TJ, Carroll NV, Read EJ, Holdford DA. The Economic Burden of Opioid Poisoning in the United
`States. Pain Medicine 2013 Oct; 14(10):1534-47.
`
`Gilligan AM, Myers J, Nash JD, Lavigne JE, Moczygemba LR, Plake KS, Quinones-Boex AC, Holdford D,
`West-Strum D, and Warholak TL. "Educating Pharmacy Students to Improve Quality (EPIQ) in Colleges
`and Schools of Pharmacy." American Journal of Pharmaceutical Education 2012; 76(6): Article 103
`
`*Joshi AD, Holdford DA, Brophy DF, Harpe SE, Mays D, Gehr TE. "Utilization patterns of IV iron and
`
`David A. Holdford
`
`
`Page 3
`
`Page 8 of 32
`
`

`
`
`Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease patients: A multi-hospital study"
`Anemia. Article ID 248430, 2012.
`
`*Patel DA, Joshi AD, Holdford DA, Saxena K. Content Analysis of Off-Label Drug Use: Reporting Print
`Media Coverage. Drug Information Journal. Vol. 45, pp. 787-796, 2011.
`
`Warholak TL, Noureldin M, West-Strum D, Holdford DA, "Faculty Perceptions of the Educating Pharmacy
`Students to Improve Quality (EPIQ) Program " American Journal of Pharmaceutical Education. 75(8)
`Article 1163, 2011.
`
`West-Strum D, Basak R, Bentley JP, PhD, Holdford DA, Warholak TL, Malone DC, Murphy JE, "The
`Science of Safety Curriculum in US Colleges and Schools of Pharmacy" American Journal of
`Pharmaceutical Education. 75(7) Article 141, 2011.
`
`Warholak TL, Holdford DA, West-Strum D, DeBake DL, Bentley JP, Malone DC, Murphy JE, "Perspectives
`on Educating Pharmacy Students about the Science of Safety " American Journal of Pharmaceutical
`Education. 75(7) Article 142, 2011.
`
`Holdford DA, Warholak TL, West-Strum D, Bentley JP, Murphy JE, Malone DC. Teaching the Science of
`Safety in U.S. Schools of Pharmacy. Report Findings. “A Baseline Evaluation of the Integration of the
`‘Science of Safety’ into the Curriculum of the Doctor of Pharmacy Degree in U.S. colleges and Schools of
`Pharmacy” American Journal of Pharmaceutical Education. 75(4) Article 77, 2011.
`
`*Patel DA, Holdford DA, Edwards E, Carroll NV. Estimating the Economic Burden of Food Allergy and
`Anaphylaxis in the United States. Journal of Allergy and Clinical Immunology
`http://www.jacionline.org/inpress posted: 14 April 2011.
`
`*Joshi AD, Patel DA, Holdford DA. Media Coverage of Off-label Promotion: A Content Analysis of US
`newspapers. Research in Social and Administrative Pharmacy, 2011 September;7(3): 257-271.
`
`Warholak TL, West-Strum D, Holdford DA. The Educating Pharmacy Students and Pharmacists to
`Improve Quality Program: Tool for pharmacy practice. J Am Pharm Assoc. 2010;50.
`
`Maxwell CB, Holdford DA, Crouch MA, Patel DA. Cost-effectiveness analysis of anticoagulation strategies
`in non-ST-elevation acute coronary syndromes. Ann Pharmacother 2009 April;43(4):586-95.
`
`Holdford DA. "Managing Yourself: An Essential Skill for Managing Others." Published simultaneously in
`Pharmacy Today. Pp. 45-54, April (2009) and Journal of the American Pharmacists Association
`49(3):436-445 (2009).
`
`Holdford DA. “Marketing of Health Promotion Programs/Activities.” Health Promotion and Maintenance.
`Pharmacotherapy Self-Assessment Program (PSAP) – Sixth Edition. Lenexa, KS: American College of
`Clinical Pharmacy. 2008:119-132.
`
`Holdford DA. “Content Analysis: Methods for Conducting Research.” Research in Social and Administrative
`Pharmacy. Vol 4. pp. 173-181 (2008).
`
`*Patkar A, Holdford DA, DF Brophy, Pyles M. “Off-Label Prescribing of Erythropoiesis-Stimulating Proteins
`in U.S. Hospitals.” Drug Information Journal: Vol 41, pp. 431-440 (2007).
`
`*Phillips S, MacDougall C, Holdford DA. “Analysis of Empiric Antimicrobial Strategies for Cellulitis in the
`Era of Methicillin-Resistant Staphylococcus aureus.” The Annals of Pharmacotherapy: Vol. 41, No. 1, pp.
`13-20 (2007).
`
`David A. Holdford
`
`
`Page 4
`
`Page 9 of 32
`
`

`
`
`
`Summers KM, Holdford DA, Crouch MA. “Cost-Effectiveness Analysis of Antithrombotic Therapy in Non-
`Urgent Percutaneous Coronary Intervention.” Pharmacotherapy. (26)5:609-618 (2006).
`
`Holdford DA. “Service Scripts - A Tool for Teaching Pharmacy Students How to Handle Common Practice
`Situations.” American Journal of Pharmaceutical Education. (70)1: Article 02: 1-7 (2006).
`
`Holdford DA. “Understanding the Dynamics of the Pharmaceutical Market Using a Social Marketing
`Framework.” The Journal of Consumer Marketing. 22 (7): 388-396 (2005).
`
`*Orensky IA, Holdford DA ““Predictors of Medication Noncompliance in the Outpatient Anticoagulation
`Clinic Setting.” Pharmacotherapy. 25(12): 1801-1808 (2005).
`
`Holdford DA. “Using Buzz to Promote Ideas, Services, and Products” J Amer Pharm Assoc. 44(3):387-
`396 (2004).
`
`Kennedy DT, Paulson DM, Eddy TD, Patel PC, Patkar A, Holdford DA, Genina VY, Griffin EN. “A smoking-
`cessation program consisting of extensive counseling, pharmacotherapy, and office spirometry: results of
`a pilot project in a Veterans Administration Medical Center.” Pharmacotherapy. Oct; 24(10):1400-7
`(2004).
`
`Stephenson A, Carroll NV, Holdford DA. “A Comparison of the Costs of Manufacturer Unit-dose and
`Repackaged Unit-dose in Seven-Day Dispensing Systems” Consultant Pharmacist 19(3):215-221(2004).
`
`Holdford DA, Patkar A. “Identifying the Service Quality Dimensions of Pharmaceutical Education.” Journal
`of Pharmaceutical Education; 67 (4) Article 108. 1-11 (2003).
`
`Holdford DA, Yom SH. “Content Analysis of Newspaper Advertising of Pharmacy Services.” Journal of
`Pharmaceutical Marketing & Management. 15 (2): 81-96 (2003).
`
`Holdford DA. “Leadership Theories and their Lessons for Pharmacists.” American Journal of Health
`System Pharmacists. 60 (17):1780-1786 (2003).
`
`Brophy DF, Ripley EBD, Holdford DA. “Pharmacoeconomic considerations in the health system
`management of anaemia inpatients with chronic kidney disease and end stage renal disease.” Expert
`Opinion in Pharmacotherapy. 4(9): 1461-1469 (2003).
`
`*Tran MT, Holdford DA, Kennedy DT, Small RE. “Modeling the Cost-Effectiveness of a Smoking Cessation
`Program in a Community Pharmacy Practice.” Pharmacotherapy. 22(12): 1623-1631. (2002).
`Corresponding Author.
`
`Holdford DA, Carroll NV. “Consumer Preferences for Types of Cost Containment in Prescription Drug
`Programs.” Journal of Managed Care Pharmacy. 8(3): 192-198. (2002)
`
`Holdford DA, Reinders TP. “Development of an Instrument to Assess Student Perceptions of the Quality
`of Pharmaceutical Education.” American Journal of Pharmaceutical Education. 65(2): 125-131. (2001)
`
`Holdford DA, Lovelace Elmore B. “Applying the Principles of Human Motivation to Pharmaceutical
`Education.” Journal of Pharmacy Teaching. 8(4):1-18. (2001).
`
`Brophy DF, Wallace JF, Kennedy DT. Gehr T. Holdford DA. “Cost-Effectiveness of Sevelamer versus
`Calcium Carbonate plus Atorvastatin to Reduce LDL in Patients with Chronic Renal Insufficiency with
`Dyslipidemia and Hyperphosphatemia.” Pharmacotherapy. 20(8): 950-957. (2000).
`
`David A. Holdford
`
`
`Page 5
`
`Page 10 of 32
`
`

`
`
`
`*Chang ZG, Kennedy DT, Holdford DA, Small RE. “Pharmacists’ Knowledge and Attitudes Towards Herbal
`Medicine.” The Annals of Pharmacotherapy. June: Vol. 34. 710-715. (2000).
`
`Holdford DA, Stratton TP. “A Marketing Plan for Recruiting Students into Pharmacy School-Based
`Graduate Programs. A Report.” American Journal of Pharmaceutical Education. Vol 64 (Winter
`Supplement):41S-47S, 2000.
`
`Holdford DA, Schulz RM. “The Effect of Technical and Functional Quality on Patient Perceptions of
`Pharmaceutical Service Quality.” Pharmaceutical Research. 9(16): 1346-1353, (1999).
`
`Holdford DA, Kennedy DT. “The Service Blueprint as a Tool for Designing Innovative Pharmaceutical
`Services.” Journal of the American Pharmaceutical Association. 39(4), 545-52 (1999).
`
`Holdford DA,. “The Role of Pharmacists in Disease State Management.” Disease Management & Health
`Outcomes. 3(6):257-270, (1998).
`
`Holdford DA, Kennedy DT, Bernadella P, Small RE. “Implementing Disease Management in Community
`Pharmacy Practice.” Clinical Therapeutics. 20(2): 328-339, 1998.
`
`Holdford DA, Smith S. “Improving the Quality of Outcomes Research Involving Pharmaceutical Services.
`American Journal of Health-System Pharmacists 54:1434-42, 1997.
`
`Holdford DA, Watrous M. “The Relative Importance Consumers Place on Pharmaceutical Services.”
`Journal of Pharmaceutical Marketing and Management. 11(4):55-68, 1997.
`
`Holdford DA, Wright SS. “Testing Trust-Commitment Theory in Relationships Between Pharmacy Schools
`and Students.” American Journal of Pharmaceutical Education. Vol 66 (Fall):249-256, 1997.
`
`Holdford DA. “Disease Management Commentary.” American Journal of Health-System Pharmacists.
`53:2093-6, 1996.
`
`Kozma CM, Schulz RM, Dickson WM, Holdford DA, et al. "Economic Impact of Cost Containment
`Strategies in Third Party Programs, Part II." Pharmacoeconomics 4 (2):92-103, 1993.
`
`
`
`PEER-REVIEWED ELECTRONIC MEDIA
`
`Warholak TL, West D, Holdford DA. 17-Module Curriculum (EPIQ) to Teach Students about Pharmacy
`Quality and Patient Safety. Pharmacy Quality Alliance (PQA) Each module consists of 50 minute
`educational sessions containing PowerPoint slides, recorded sessions, student activities, evaluation
`questions, teacher’s guide, suggested readings, evaluation forms, and implementation options.
`
`Version 2.0 (2014)
`
`
`Holdford DA. Session 1 – Quality and the Future of Health Care -- Health Care Reform, What Does It
`Mean?
`Holdford DA. Session 3 – The Business Case for Pharmacy Quality
`Holdford DA. Session 5 – What is Quality Improvement? Statistical Process Control?
`Holdford DA. Session 6 – Knowing There is a Problem. Recognizing and Defining Quality Problems
`Holdford DA. Session 7 – Knowing What Lead to the Problem. Identifying Causes of Quality
`Problems
`Holdford DA. Session 12 - Measurement of Safety and Quality
`
`David A. Holdford
`
`
`Page 6
`
`Page 11 of 32
`
`

`
`
`
`Holdford DA. Session 23 - Star Measures and Payment Incentives
`
`
`Version 1.0 (2008)
`
`
`Holdford DA. Session 1 – Quality and the Future of Health Care
`Holdford DA. Session 2 – Understanding Problems in the Use of Medications
`Holdford DA. Session 3 – The Business Case for Pharmacy Quality
`Holdford DA. Session 6 – Recognizing and Defining Quality Problems
`Holdford DA. Session 8 – Statistical Process Control
`Holdford DA. Session 10 - CAHPS Measures
`
`Holdford DA. “Introduction to Outcomes Research”. International Society of Pharmacoeconomics and
`Outcomes Research Distance Learning Module. www.ispor.org Accepted for online use Sept. 8, 2008.
`
`
`
`
`
`SUBMITTED WORK UNDER REVIEW OR ACCEPTED
`
`
`Martin LC, Donohoe KL, Holdford DA. Decision-making and Problem Solving Approaches in Pharmacy
`Education. (In review for publication in American Journal of Pharmaceutical Education)
`
`Patterson, JA, Holdford DA, Saxena K. Cost Benefit Analysis of Appointment-Based Medication
`Synchronization (ABMS) in Community Pharmacies. (Submitted for Review).
`
`Seetasith A, Holdford DA, Shaw A. Patterson JA. On-label and off-label use and prescribing patterns of
`erythropoietin-stimulating agents in inpatient hospital settings in the US. (Submitted for Review).
`
`
`
`PROFESSIONAL PUBLICATIONS
`
`Moulton JR, Holdford DA, West-Strum D, Warholak TL, Cranston L, Advancing pharmacy practice through
`performance measurement: future implications. Drug Store News. Pgs 1-6. April 2009,
`www.cedrugstorenews.com/userapp/lessons/lesson_view_ui.cfm?lessonuid=401-999-09-004-H04.
`
`Holdford DA, Liang BA, The growing influence of generic drugs: what it means to pharmacists and
`physicians. Power-Pak C.E. A Publication from the Postgraduate Institute for Medicine. Pgs 1-12.
`December 2006.
`
`Anderson A, Goode K, Swiger K, Holdford D: “Assessment of Participation in a Pharmacy-Based Employee
`Wellness Program,” Journal of the American Pharmacist Assoc, 45:249, 2005.
`
`Holdford DA. “Transparency Needed for Economic Analyses of Prior Authorization Programs.” Letters.
`Journal of Managed Care Pharmacy. 9 (6); 576. (2003).
`
`Holdford DA. “How Pharmacists Use Pharmacoeconomics to Understand the Value of Drugs.” Richmond
`Times Dispatch. National Pharmacy Week Supplement. Oct. 15. 2003.
`
`Davis KC, Kennedy DT, Holdford DA, Small RE. “Evaluation of Patient Adherence from a Telephone
`Intervention Program in Community Pharmacy Practice.” Virginia Pharmacist. November: 23-27. (2000).
`
`Holdford DA. “Opportunities Outside of the Pharmacy School Classroom.” Virginia Pharmacist. 84(6): 9-
`10(2000).
`
`Holdford DA, Carroll NV. “Virginia Commonwealth University Initiates Combined Graduate Programs.”
`
`David A. Holdford
`
`
`Page 7
`
`Page 12 of 32
`
`

`
`
`Journal of Managed Care Pharmacy. 6(4):282-283, (2000).
`
`Holdford DA. “Negotiating with Your Employer: Tactics .” Transitions. Vol.1. No. 1. Winter:5-6, (2000)
`
`Chang ZG, Kennedy DT, Holdford DA, Small RE. “Payment for Pharmaceutical Services.” Virginia
`Pharmacist. January: 11-16. (2000).
`
`Holdford DA. “Negotiating with Your Employer: General Principles.” Career Manager. APhA New
`Practitioner Initiative Publication. Fall: 1-8, (1999).
`
`Holdford DA. “Marketing Your Ideas Through Persuasion.” Career Manager. APhA New Practitioner
`Initiative Publication. Summer: 1-8, (1999).
`
`Holdford DA. “Review of the Decision Analysis System Software Package by Armada System.” American
`Society of Hospital Pharmacists. June 1996.
`
`
`
`BOOKS CHAPTERS AUTHORED
`
`Holdford DA. Chapter 96: Marketing Pharmacy Care Services. Remington: The Science and Practice of
`Pharmacy. Lippincott Williams & Wilkins. Twenty-Second Edition. 2012.
`
`Uselton JP, Murdaugh LB, Kienle PC, Holdford DA. Chapter 3: Key Legal and Regulatory Issues in
`Institutional Pharmacy Practice. In: Holdford DA, Brown TR, editors. Introduction to Hospital and
`Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of Health-Systems
`Pharmacists; pp. 39-58; 2010.
`
`Holdford DA. Chapter 6: Medication Safety. In: Holdford DA, Brown TR, editors. Introduction to Hospital
`and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of Health-Systems
`Pharmacists; pp. 99-122; 2010.
`
`Holdford DA. Chapter 9: Electronic Data Management: Electronic Health-Record Systems and
`Computerized Provider Order-Entry Systems. In: Holdford DA, Brown TR, editors. Introduction to Hospital
`and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of Health-Systems
`Pharmacists; pp. 159-178; 2010.
`
`Holdford DA. Chapter 16: Leadership and Management. In: Holdford DA, Brown TR, editors. Introduction
`to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of
`Health-Systems Pharmacists; pp. 321-342; 2010.
`
`Holdford DA. Chapter 17: Recruiting, Selecting, and Managing Pharmacy Personnel. In: Holdford DA,
`Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda,
`Maryland: American Society of Health-Systems Pharmacists; pp. 39-58; 2010.
`
`Reinders TP, Holdford DA. Chapter 18: Training for Careers in IPP. In: Holdford DA, Brown TR, editors.
`Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American
`Society of Health-Systems Pharmacists; pp. 321-344; 2010.
`
`Holdford DA. The Business Case for Pharmacy Quality. In: Warholak TL, Nau D, editors. Quality and
`Safety in Pharmacy Practice. New York. N.Y.: McGraw Hill; pp. 25-36; 2010.
`
`Holdford DA. Recognizing and Defining Quality Problems. In: Warholak TL, Nau D, editors. Quality and
`Safety in Pharmacy Practice. New York. N.Y.: McGraw Hill; pp. 71-80; 2010.
`
`David A. Holdford
`
`
`Page 8
`
`Page 13 of 32
`
`

`
`
`
`Moczygemba LR, Holdford DA. Statistical Process Control. In: Warholak TL, Nau D, editors. Quality and
`Safety in Pharmacy Practice. New York. N.Y.: McGraw Hill; pp. 99-111; 2010.
`
`Holdford, David A. “Chapter 9: Human Resources Management Functions.” Pharmacy Management: 2nd
`Edition. McGraw Hill Publishing. Desselle, S. and Zagarrick, D.; Editors. pp. 149-164; 2008.
`
`Holdford, David A. “Chapter 1: Editorial Comments.” Pharmacy and the Pharmaceutical Industry:
`Healing the Rift. The Haworth Press, Birmingham, N.Y. 2008. pp. 1-10; 2008.
`
`Holdford, David A. “Chapter 3: Leadership Theories for Leading Change.” Leadership and Advocacy for
`Pharmacy. 1st Edition. American Pharmacists Association Publications, Washington, DC. Boyle, C.J.;
`Beardsley, R.S.; Holdford, D.A.; Editors. pp. 27-41; 2007.
`
`Holdford, David A. “Chapter 14: Leadership Using Public Relations to Advocate for the Profession.”
`Leadership and Advocacy for Pharmacy. 1st Edition. American Pharmacists Association Publications,
`Washington, DC. Boyle, C.J.; Beardsley, R.S.; Holdford, D.A.; Editors. pp. 167-179; 2007.
`
`Holdford, David A. (Author/Editor) Marketing for Pharmacists: Providing and Promoting Professional
`Services, 2nd Edition. American Pharmacists Association Publications, Washington, DC. pp. 1-333; 2007.
`Chapters Authored:
`• Chapter 1: Introduction to Marketing Pharmaceutical Services pp. 3-22
`• Chapter 2: Important Marketing Ideas pp. 23-42
`• Chapter 3: Characteristics of Services pp. 43-66
`• Chapter 4: Managing the Service Performance pp. 67-82
`• Chapter 5: Designing Pharmaceutical Services pp. 83-106
`• Chapter 6: Consumer Behavior pp. 107-130
`• Chapter 7: Consumer Evaluations of Services pp. 131-150
`• Chapter 8: Strategic Marketing Planning pp. 151-176
`• Chapter 9: Marketing Strategies pp. 177-206
`• Chapter 10: Market Segmentation pp. 207-236
`• Chapter 11: Marketing Communication pp. 237-264
`
`Holdford DA. “Chapter 10: Human Resources Management Functions.” Pharmacy Management.
`McGraw Hill Publishing. Desselle, S. and Zagarrick, D.; Editors. pp. 171-183; 2004.
`
`Holdford DA. Marketing for Pharmacists. 1st Edition. American Pharmaceutical Association Publications,
`Washington, DC. pp. 1-298; 2003.
`Chapters Authored:
`Chapter 1: Introduction to Marketing Pharmaceutical Services pp. 3-22
`Chapter 2: Important Marketing Ideas pp. 18-38
`Chapter 3: Characteristics of Services pp. 39-60
`Chapter 4: Managing the Service Performance pp. 61-74
`Chapter 5: Designing Pharmaceutical Services pp. 75-102
`Chapter 6: Consumer Behavior pp. 103-121
`Chapter 7: Consumer Evaluations of Services pp. 122-142
`Chapter 8: Strategic Marketing Planning pp. 143-168
`Chapter 9: Marketing Strategies pp.169-196
`Chapter 10: Market Segmentation pp. 197-222
`Chapter 11: Marketing Communication pp. 223-244
`
`
`Schulz RM, Holdford DA. "Definitions and Meaning of Health," Social and Behavioral Aspects of
`Pharmaceutical Care, The Haworth Press, Inc. Binghamton, NY. 1996.
`
`David A. Holdford
`
`
`Page 9
`
`Page 14 of 32
`
`

`
`
`BOOK CHAPTERS EDITED
`
`Kasey K. Thompson and Douglas J. Scheckelhoff. Chapter 1: What is Institutional Pharmacy Practice? In:
`Holdford DA, Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed.
`Bethesda, Maryland: American Society of Health-Systems Pharmacists; pp. 1-16; 2010.
`
`William A. Zellmer. Chapter 2: Overview of the History of Hospital Pharmacy in the United States. In:
`Holdford DA, Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed.
`Bethesda, Maryland: American Society of Health-Systems Pharmacists; pp. 17-38; 2010.
`
`Kathy A. Chase. Chapter 4: Medication Management. In: Holdford DA, Brown TR, editors. Introduction to
`Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of Health-
`Systems Pharmacists; pp. 59-80; 2010.
`
`John E. Murphy. Chapter 5: Clinical Pharmacy. In: Holdford DA, Brown TR, editors. Introduction to
`Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of Health-
`Systems Pharmacists; pp. 81-98; 2010.
`
`Stephen F. Eckel and Fred M. Eckel. Chapter 7: Medication Distribution Systems. In: Holdford DA, Brown
`TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland:
`American Society of Health-Systems Pharmacists; pp. 123-142; 2010.
`
`George J. Dydek and David J. Tomich. Chapter 8: Controlled Substances Management In: Holdford DA,
`Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda,
`Maryland: American Society of Health-Systems Pharmacists; pp. 143-158; 2010.
`
`James G. Stevenson, Scott R. McCreadie, and Bruce W. Chaffee. Chapter 10: Informatics. In: Holdford
`DA, Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda,
`Maryland: American Society of Health-Systems Pharmacists; pp. 179-202; 2010.
`
`Brad Ludwig and Jack Temple. Chapter 11: Automation in Practice. In: Holdford DA, Brown TR, editors.
`Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American
`Society of Health-Systems Pharmacists; pp. 203-228; 2010.
`
`Jerrod Milton. Chapter 12: Purchasing and Inventory Control. In: Holdford DA, Brown TR, editors.
`Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American
`Society of Health-Systems Pharmacists; pp. 229-252; 2010.
`
`Andrew L. Wilson. Chapter 13: Basics of Financial Management and Cost Control. In: Holdford DA, Brown
`TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland:
`American Society of Health-Systems Pharmacists; pp. 253-276; 2010.
`
`Philip J. Schneider and E. Clyde Buchanan. Chapter 14: Sterile Preparations and Admixture Programs. In:
`Holdford DA, Brown TR, editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed.
`Bethesda, Maryland: American Society of Health-Systems Pharmacists; pp. 277-298; 2010.
`
`E. Clyde Buchanan. Chapter 15: Parenteral Therapy. In: Holdford DA, Brown TR, editors. Introduction to
`Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland: American Society of Health-
`Systems Pharmacists; pp. 299-320; 2010.
`
`Jill S. Burkiewicz and Carrie A. Sincak. Chapter 19: Residency Training. In: Holdford DA, Brown TR,
`editors. Introduction to Hospital and Health-System Pharmacy Practice. 1st ed. Bethesda, Maryland:
`American Society of Health-Systems Pharmacists; pp. 383-398; 2010.
`
`David A. Holdford
`
`
`Page 10
`
`Page 15 of 32
`
`

`
`
`
`Holdford, David A. (Editor). Pharmacy and the Pharmaceutical Industry: Healing the Rift.
`The Haworth Press, Birmingham, N.Y. 2008. pp. 1-108; 2008.
`• Albert Wertheimer. Conflict Between the Pharmaceutical Industry and Pharmacists. Pp. 11-20.
`• Norman V. Carroll. Examine the Rift Between the Pharmaceutical Industry and the Pharmacy
`Profession: A Channels of Distribution